EU regulator studying data on booster dose for Pfizer COVID-19 vaccine

mediabest
FILE PHOTO: A vial labelled with the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine is seen in this illustration picture taken March 19, 2021. REUTERS/Dado Ruvic/Illustration

(Reuters) – Europe’s medicines regulator said on Monday it was evaluating data on a booster dose for the COVID-19 vaccine developed by Pfizer/BioNTech, to be given six months after the second dose in people aged 16 years and older.

The European Medicines Agency said it would carry out a speedy evaluation of the data, with an outcome expected “within the next few weeks”. It also added that it was also assessing data on the use of an additional dose of mRNA vaccines in people with weak immune systems.

Source: Read Full Article

Related posts:
  1. Pfizer begins early-stage study of oral COVID-19 drug
  2. Biden says CDC guidance on reopening schools is solid science
  3. Nigerian students design coronavirus care robot
  4. Hungary reports record 8,312 coronavirus infections in 24 hours
  5. Japan government spokesman says ministers share urgency over record COVID spike